Detalhe da pesquisa
1.
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.
Lancet
; 401(10394): 2124-2137, 2023 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37302395
2.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 24(12): 1359-1374, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926100
3.
Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015).
Breast Cancer Res
; 25(1): 39, 2023 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046348
4.
Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study.
Breast Cancer Res
; 24(1): 61, 2022 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096872
5.
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
JAMA
; 327(20): 1963-1973, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608580
6.
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Lancet
; 395(10237): 1613-1626, 2020 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580883
7.
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial.
Lancet Oncol
; 21(11): 1443-1454, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152284
8.
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.
Lancet Oncol
; 21(10): 1296-1308, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32919527
9.
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial - Authors' reply.
Lancet
; 403(10438): 1752, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704171
10.
The Lancet Breast Cancer Commission.
Lancet
; 403(10439): 1895-1950, 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38636533
11.
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
Lancet Oncol
; 20(7): 1023-1034, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31160249
12.
Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients.
Breast Cancer Res
; 22(1): 2, 2019 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31892336
13.
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES.
Breast Cancer Res Treat
; 175(1): 149-163, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30680659
14.
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Lancet
; 390(10099): 1048-1060, 2017 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28779963
15.
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer.
Breast Cancer Res Treat
; 171(1): 65-74, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29766362
16.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 18(7): 929-945, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600210
17.
Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.
Lancet Oncol
; 17(2): 184-192, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26790922
18.
Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas.
Breast Cancer Res
; 18(1): 39, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27036195
19.
Accelerated partial breast irradiation: more questions than answers?
Lancet
; 394(10215): 2127-2129, 2019 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31813634
20.
Targeted radiotherapy for early breast cancer - Authors' reply.
Lancet
; 391(10115): 27-28, 2018 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29323651